Clinical Guide: Managing GLP-1 Ocular Manifestations and NAION Risks in Optometric Practice

episode

Defocus Media Eyecare and Optometry Podcast Network not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

#502 – Psychiatry, Insane Asylums, Mental Illness, ECT, Lobotomies, Freud & Jung 3h 43m · 17 Sep 2026 · Lex Fridman Podcast

Your partner wants profit. You want freedom. Now what? 22 min · 16 Sep 2026 · The Optometry Success Podcast

Board of County Supervisors Meeting - Work Session - Sep 15, 2026 3h 17m · 15 Sep 2026 · Prince William County Board of Supervisors

Finance and Budget Committee - Sep 15, 2026 1h 43m · 15 Sep 2026 · Prince William County Finance and Budget Committee

Sept. 15, 2026 Board of Supervisors Meeting 8h 46m · 15 Sep 2026 · Fairfax County Board of Supervisors

The Art of True Happiness | Dr. Arthur Brooks 2h 49m · 14 Sep 2026 · Huberman Lab

Report any issue

Source

Recorded09 Feb 2026

Publisherdefocusmediagroup.com ↗

Handlerec:15803259

Show notes

This SEO-optimized clinical briefing is designed for the optometric community. It synthesizes the AOA Evidence-Based Optometry (EBO) Committee June 2025 clinical report with the professional insights of Dr. Andrew Morgenstern, Director of the AOA Clinical Resources Group, regarding the management of patients on GLP-1 receptor agonists.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in